MUSCULAR ATROPHY
Clinical trials for MUSCULAR ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MUSCULAR ATROPHY trials appear
Sign up with your email to follow new studies for MUSCULAR ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Knee surgery recovery boost? supplements show promise in small pilot
Disease control CompletedThis pilot study tested whether taking omega-3 fatty acids and essential amino acids before and after knee surgery could help prevent muscle loss. Thirty adults scheduled for ACL reconstruction took either the supplements or a placebo for 4 weeks before and 2 weeks after surgery.…
Matched conditions: MUSCULAR ATROPHY
Phase: NA • Sponsor: Dr. Chris McGlory, PhD • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
New drug shows promise for muscle strength in SMA patients on standard therapy
Disease control CompletedThis study tested a drug called apitegromab in 188 people aged 2 to 21 with later-onset spinal muscular atrophy (SMA types 2 and 3) who were already taking nusinersen or risdiplam. The goal was to see if adding apitegromab could improve muscle function more than a placebo. Partic…
Matched conditions: MUSCULAR ATROPHY
Phase: PHASE3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Exercise and protein shakes show promise for aging muscles
Symptom relief CompletedThis study looked at whether combining aerobic and resistance exercise with protein supplements can improve muscle mass, strength, balance, and quality of life in older adults with age-related muscle loss (sarcopenia). About 110 people aged 60-90 took part. The goal was to find a…
Matched conditions: MUSCULAR ATROPHY
Phase: NA • Sponsor: Liverpool Hope University • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC